On May 19, Novavax, Inc. (“Novavax”) announced that FDA approved its Biologics License Application (“BLA”) for Nuvaxovid™ for active immunization against COVID-19 in adults 65 years and older and ...

The U.S. Food and Drug Administration has granted limited approval to Novavax Inc.’s NVAX COVID-19 vaccine, restricting its use to people 65 and older and those 12 and up with underlying health ...

Novavax, Inc. (NASDAQ:NVAX) is one of the 11 Best Short Squeeze Stocks to Buy Now. The company’s non-mRNA COVID-19 vaccine is approved, strengthening its Sanofi partnership. Novavax, Inc. (NASDAQ:NVAX ...

By Mariam Sunny and Michael Erman Feb 26 (Reuters) - Novavax raised its adjusted revenue forecast for 2026 on Thursday, ...

Novavax (NASDAQ:NVAX) shares climbed more than 17% premarket on Monday after the long-awaited approval of its COVID-19 vaccine from the U.S. FDA. The FDA cleared the biologics license application for ...

We recently compiled a list of the 11 Cheap Biotech Stocks to Buy According to Hedge Funds. Novavax, Inc. is one of them. Novavax, Inc. (NASDAQ:NVAX) is a biotechnology company specializing in ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Nuvaxovid becomes the only non-messenger RNA COVID-19 ...

Feb 26 (Reuters) - Novavax ⁠raised ⁠its adjusted revenue forecast for ⁠2026 on Thursday, banking on milestone payments from licensing and supply deals for its shots, although it noted that the current ...